Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
The delta F508 mutation decreases the stability of cystic fibrosis transmembrane conductance regulator in the plasma membrane. Determination of functional half-lives on transfected cells
Ist Teil von
The Journal of biological chemistry, 1993-10, Vol.268 (29), p.21592-21598
Ort / Verlag
Bethesda, MD: American Society for Biochemistry and Molecular Biology
Erscheinungsjahr
1993
Quelle
MEDLINE
Beschreibungen/Notizen
Deletion of the phenylalanine at position 508 of the cystic fibrosis transmembrane conductance regulator (CFTR) is the most
prevalent mutation in cystic fibrosis (CF). This mutation (delta F508CFTR) leads to a reduced cAMP-sensitive Cl- conductance
in epithelial cells. While the mutant protein can function as a Cl- channel, it seems to be misprocessed and unable to accumulate
at normal levels in the plasma membrane. Under conditions where the biosynthetic block of delta F508CFTR is not complete,
the residence time of delta F508CFTR in the plasma membrane is a critical determinant of the cAMP-sensitive Cl- conductance.
To assess the stability of the mutant and wild-type CFTR, we compared their functional half-lives at the plasma membrane of
transfected Chinese hamster ovary cells. The plasma membrane Cl- conductance was assessed by patch-clamp recordings and/or
by fluorimetric determinations of the membrane potential. Accumulation of delta F508CFTR in the plasma membrane was promoted
by growing the transfected cells at reduced temperature (24-28 degrees C), and was verified by immunoblotting and by detecting
the appearance of a plasmalemmal cAMP-activated Cl- conductance. Subsequently increasing the temperature to 37 degrees C inhibited
further delivery of newly synthesized delta F508CFTR to the surface membrane. By studying the time dependence of the disappearance
of the Cl- conductance, the functional half-life of the mutant protein at the plasma membrane was determined to be < 4 h,
which is considerably shorter than the half-life of wild-type CFTR (> 24 h). The latter was estimated by terminating protein
synthesis or secretion with cycloheximide or brefeldin A, respectively. Inhibition of protein synthesis did not alter the
rate of disappearance of delta F508CFTR at 37 degrees C, validating the difference in turnover between mutant and wild-type
CFTR. These results indicate that the structural abnormality of delta F508CFTR affects not only the delivery of the protein
to the plasma membrane, but also its stability therein. Moreover, they suggest that overcoming the processing block at the
endoplasmic reticulum may not suffice to restore normal Cl- conductance in CF.